Fortem Financial Group, LLC Edwards Lifesciences Corp Transaction History

Fortem Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$86.5 - $128.27 $173,000 - $256,540	-2,000 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$101.96 - $128.34 $2,039 - $2,566	-20 Reduced 0.99%	2,000 $235,000
Q2 2021 Jul 14, 2021	BUY	$83.84 - $104.76 $169,356 - $211,615	2,020 New	2,020 $209,000
Q1 2021 Apr 20, 2021	SELL	$78.68 - $90.67 $166,801 - $192,220	-2,120 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$71.69 - $91.23 $151,982 - $193,407	2,120 New	2,120 $193,000

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortem Financial Group, LLC with notifications on news.